Intelligencia.AI.png

Intelligencia.ai

IT/Software platform

Membership category
Corporate

Leof. Andrea Syggrou 80-88, Athens, 11741, Greece

Intelligencia.ai at a glance

Intelligencia is a technology company that focuses on reducing the risk of drug development with the ultimate goal of bringing novel therapies to patients faster.

About Intelligencia.ai

Intelligencia combines exceptional data with the computational power of AI to quantify and improve clinical success and to enhance sourcing of external innovation. Intelligencia's customers - large pharmaceutical companies and biotechs ranging from multi-billion large-cap to emerging preclinical - use Intelligencia's platform to: - assess the probability of technical and regulatory success (PTRS) of their development programs and minimise any risks. - optimise trial design and evaluate additional indications for a clinical asset. - evaluate the relative attractiveness of external assets. - predict likely future areas of scientific innovation.

Therapeutic area(s)

Articles Intelligencia.ai has contributed to